在住院COVID-19患者中进行血栓预防的全方位临床决策支持工具:IMPROVE-DD集群随机试验的后期分析

Mark Goldin1, Nikolaos Tsaftaridis2, Ioannis Koulas3

  • 1Northwell, New Hyde Park, New York, USA; Institute of Health System Science, Feinstein Institutes for Medical Research, Manhasset, New York, USA; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.

概括

一种新的临床决策支持工具改善了COVID-19患者的血栓预防,减少了静脉血栓栓塞和再入院,而不会增加出血风险.